Analysts at Bank of America initiated coverage on shares of OrganiGram (NASDAQ:OGI) in a research report issued to clients and investors on Monday, January 13th, Marketbeat Ratings reports. The firm set an “underperform” rating on the stock.
OGI has been the topic of several other reports. Jefferies Financial Group raised shares of OrganiGram from a “hold” rating to a “buy” rating and set a $8.20 target price on the stock in a research note on Friday, October 11th. Zacks Investment Research raised shares of OrganiGram from a “sell” rating to a “hold” rating in a research note on Saturday, January 4th. CIBC began coverage on shares of OrganiGram in a research note on Tuesday, September 24th. They issued an “outperformer” rating and a $9.00 price target on the stock. Beacon Securities lowered shares of OrganiGram from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Finally, BMO Capital Markets downgraded shares of OrganiGram from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. OrganiGram presently has an average rating of “Hold” and an average target price of $9.80.